| Website | epicsciences.com |
| @EpicSciences | |
| cdx@epicsciences.com | |
| Employees | |
| Founded | 2008 |
| TOTAL | $13M |
| FUNDING TOTAL | $13M |
| Series B, 11/12 Domain Associates Roche Venture Fund Pfizer Venture Investments | $13M |
Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine. Epic is founded on a powerful platform to identify and characterize rare cells including circulating tumor cells (“CTCs”). Epic is working with a number of partners including numerous pharmaceutical companies, major cancer centers, the National Cancer Institute, and the National Institutes of Health.
